⚡ For Research Use Only — Not for Human Consumption
General8 min read

Native Chemical Ligation Explained: How Two Peptides Join Into One Protein

How native chemical ligation (NCL) joins two unprotected peptide fragments at a cysteine: the C-terminal thioester, the N-terminal cysteine, the S-to-N acyl shift, and the desulfurization, selenium and expressed-protein-ligation extensions that build whole proteins.

Dynamite Research Team · November 19, 2026

Short answer: Native chemical ligation (NCL) is a reaction that joins two unprotected peptide fragments at a cysteine residue to form a single polypeptide with an ordinary (native) peptide bond at the junction. One fragment carries a C-terminal thioester, the other starts with an N-terminal cysteine; they react in water-based buffer to give a thioester-linked intermediate that then rearranges on its own into the full-length product [1][2]. The method, first reported in 1994, is one of the main reasons chemists can now build proteins, not just short peptides, from scratch [1][3].

This article is educational chemistry for laboratory readers. It describes a bond-forming reaction, not effects in people or animals, and is not guidance for human or animal use.

The length problem NCL solves

Solid-phase peptide synthesis is excellent for short to medium chains, but efficiency drops as the chain grows, because every residue is added in a step that is never perfectly complete. That practical ceiling left most proteins out of reach of pure chemistry. NCL gets around it with a divide-and-conquer logic: make two (or more) manageable fragments by synthesis, then stitch them together in solution [3]. Over the roughly two decades after it was introduced, this approach drove a large increase in the number of proteins accessible by total chemical synthesis and semi-synthesis, and it kept pushing the record for the size of protein that ligation chemistry can reach [3].

How the reaction works

The original description is compact: a chemoselective reaction of two unprotected peptide segments gives an initial thioester-linked species, and a spontaneous rearrangement of that transient intermediate yields a full-length product with a native peptide bond at the ligation site [1]. In practice that happens in two connected moves:

  • Transthioesterification. The thiol of the N-terminal cysteine on one fragment attacks the C-terminal thioester on the other. This swap is reversible and chemoselective: it singles out the cysteine thiol even though the peptides are otherwise unprotected [2].
  • S-to-N acyl shift. The resulting thioester-linked intermediate has the cysteine's free amino group positioned next to the new ester. An intramolecular rearrangement moves the acyl group from sulfur to nitrogen, forming a normal amide bond and regenerating the cysteine side-chain thiol [2].
The second step is essentially irreversible, which pulls the reversible first step forward and gives a clean native junction [2].

Why unprotected fragments matter

A defining feature of NCL is that the peptide fragments do not need their side chains protected [2]. That chemoselectivity, the reaction homing in on the N-terminal cysteine, is what lets two fully deprotected pieces meet in aqueous buffer and join at exactly one place [2]. It is also what makes the method robust enough to have become a workhorse for linking peptide and protein segments [3].

What goes into a ligation

NCL depends on two building blocks and the conditions that keep them reactive:

  • A peptide thioester for the C-terminal fragment. Getting reliable access to peptide thioesters has been an active area of method development, and improved routes to them are one reason the technique has spread [3].
  • An N-terminal cysteine on the other fragment, supplying the thiol that starts the exchange and the amine that captures the acyl group [1][2].
  • Thiol additives, buffers and catalysts. Reviews of the mechanism catalogue the solvents, reagents, additives and catalysts commonly used to run these ligations and to speed the thiol-exchange step [2].

Getting past the cysteine requirement

The classic reaction needs a cysteine at the junction, and cysteine is one of the less common amino acids, so a strict version would limit where two fragments can be joined. Two families of extensions widen the options:

  • Desulfurization and deselenization. After ligation at a cysteine, the sulfur can be removed to convert that cysteine into an alanine, so the junction no longer has to sit at a native cysteine. Related selenium-based chemistry does the same through deselenization [3].
  • Thiol- and selenol-derived amino acids. Purpose-built amino acids that carry a thiol or selenol handle let chemists place a ligation site at many more positions, then remove the handle afterward [2][3].
A broad 2019 review frames NCL and these follow-on methods through the chemistry of O,S-, N,S-, and N,Se-acyl shift systems and the thiol- or selenol-based surrogates that make them work [2].

Expressed protein ligation

NCL does not have to start from two synthetic pieces. When it is combined with a protein fragment made in cells by recombinant expression, the approach is called expressed protein ligation (EPL) [3]. That pairing lets researchers attach a precisely made synthetic piece, carrying a label or a modification, to a large biologically produced segment.

What NCL makes possible

Because the fragments are built by chemistry, a ligation can place things into a protein that a cell would not install on its own [3]:

  • Non-proteinogenic amino acids, such as D-amino acids, at defined positions (see D-amino acids) [3].
  • Fluorescent labels and other tags at a single chosen site [3].
  • Defined post-translational modifications (see post-translational modification), stitched in by assembling pre-modified fragments [3].
Beyond protein synthesis itself, the first NCL paper also showed the ligated polypeptide could be folded and oxidized into a native, disulfide-containing protein, and the review literature points to uses well outside total synthesis, including bioconjugation, polymer synthesis and materials science [1][2].

Common questions

What is native chemical ligation in one sentence?
It is the chemoselective reaction of a C-terminal peptide thioester with an N-terminal cysteine peptide to give a single product joined by a normal peptide bond [2].

Why is it called "native"?
Because the bond formed at the junction is an ordinary peptide (amide) bond, the same kind found throughout a natural protein backbone, not a surrogate linkage [1].

When was NCL introduced?
It was first reported in 1994, in a paper titled "Synthesis of proteins by native chemical ligation" [1][3].

Does it require protecting groups on the side chains?
No. The fragments are used unprotected; the reaction's selectivity for the N-terminal cysteine is what makes that possible [2].

What if there is no cysteine where I want to ligate?
Desulfurization (cysteine to alanine) and thiol- or selenol-derived amino acids let you ligate and then convert the junction, so a native cysteine is no longer required [2][3].

Bottom line

Native chemical ligation turns two unprotected peptide fragments into one protein by a thiol exchange at an N-terminal cysteine followed by a spontaneous shift that leaves a native peptide bond [1][2]. With desulfurization, selenium chemistry and expressed protein ligation layered on top, it is the backbone of modern chemical protein synthesis [2][3].


All products are for research use only — not for human or animal consumption.

References

Peer-reviewed studies referenced in this article. Links open the published source on PubMed / PubMed Central.

  1. 1. Synthesis of proteins by native chemical ligation — Science, 1994.
  2. 2. Native Chemical Ligation and Extended Methods: Mechanisms, Catalysis, Scope, and Limitations — Chem Rev, 2019.
  3. 3. Native chemical ligation in protein synthesis and semi-synthesis — Chem Soc Rev, 2018.

⚠ Research Use Only

All information on this page is for informational and research purposes only. This content does not constitute medical advice. All products sold by Dynamite Research Peptides are strictly for in-vitro laboratory research and are not approved, intended, or suitable for human or animal consumption. The products sold here are not FDA-approved drugs.

© 2026 Dynamite Research Peptides. All content for research purposes only.